Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2010

Open Access 01-12-2010 | Case report

Autoimmune hepatitis triggered by nitrofurantoin: a case series

Authors: Sally Appleyard, Ruma Saraswati, David A Gorard

Published in: Journal of Medical Case Reports | Issue 1/2010

Login to get access

Abstract

Introduction

Drugs can occasionally trigger the onset of autoimmune liver disease.

Case presentation

Three Caucasian women (aged 65, 42 and 74 years old) who were receiving long-term nitrofurantoin as prophylaxis against recurrent urinary tract infections developed hepatitic liver disease. Serological auto-antibody profiles and liver histology appearances were consistent with autoimmune hepatitis. Two of the patients presented with jaundice, and one required a prolonged hospital admission for liver failure. In all three patients nitrofurantoin was withdrawn, and long-term immunosuppressive therapy with prednisolone and azathioprine or mycophenolate was given. The patients responded well, with liver biochemistry returning to normal within a few months.

Conclusions

Although nitrofurantoin rarely causes autoimmune hepatitis, this antimicrobial is increasingly used as long-term prophylaxis against recurrent urinary tract infection. General practitioners and urologists who prescribe long-term nitrofurantoin therapy should be aware of this adverse effect.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hoyumpa AM, Connell AM: Methyldopa hepatitis. Report of three cases. Am J Dig Dis. 1973, 18: 213-222. 10.1007/BF01071975.CrossRefPubMed Hoyumpa AM, Connell AM: Methyldopa hepatitis. Report of three cases. Am J Dig Dis. 1973, 18: 213-222. 10.1007/BF01071975.CrossRefPubMed
2.
go back to reference Gough A, Chapman S, Wagstaff K, Emery P, Elias E: Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J. 1996, 312: 169-172.CrossRef Gough A, Chapman S, Wagstaff K, Emery P, Elias E: Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J. 1996, 312: 169-172.CrossRef
3.
go back to reference Brumfitt W, Hamilton-Miller JM: Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother. 1998, 42: 363-371. 10.1093/jac/42.3.363.CrossRefPubMed Brumfitt W, Hamilton-Miller JM: Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother. 1998, 42: 363-371. 10.1093/jac/42.3.363.CrossRefPubMed
4.
go back to reference Fagrell B, Strandberg I, Wengle B: A nitrofurantoin-induced disorder simulating chronic active hepatitis. A case report. Acta Med Scand. 1976, 199: 237-239. 10.1111/j.0954-6820.1976.tb06724.x.CrossRefPubMed Fagrell B, Strandberg I, Wengle B: A nitrofurantoin-induced disorder simulating chronic active hepatitis. A case report. Acta Med Scand. 1976, 199: 237-239. 10.1111/j.0954-6820.1976.tb06724.x.CrossRefPubMed
5.
go back to reference Black M, Rabin L, Schatz N: Nitrofurantoin-induced chronic active hepatitis. Ann Intern Med. 1980, 92: 62-64.CrossRefPubMed Black M, Rabin L, Schatz N: Nitrofurantoin-induced chronic active hepatitis. Ann Intern Med. 1980, 92: 62-64.CrossRefPubMed
6.
go back to reference Sharp JR, Ishak KG, Zimmerman HJ: Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med. 1980, 92: 14-19.CrossRefPubMed Sharp JR, Ishak KG, Zimmerman HJ: Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med. 1980, 92: 14-19.CrossRefPubMed
7.
go back to reference Mollison LC, Angus P, Richards M, Ireton J: Hepatitis due to nitrofurantoin. Med J Aust. 1992, 156: 347-349.PubMed Mollison LC, Angus P, Richards M, Ireton J: Hepatitis due to nitrofurantoin. Med J Aust. 1992, 156: 347-349.PubMed
8.
go back to reference Hebert MF, Roberts JP: Endstage liver disease associated with nitrofurantoin requiring liver transplantation. Ann Pharmacother. 1993, 27: 1193-1194.PubMed Hebert MF, Roberts JP: Endstage liver disease associated with nitrofurantoin requiring liver transplantation. Ann Pharmacother. 1993, 27: 1193-1194.PubMed
9.
go back to reference Edoute Y, Karmon Y, Roguin A, Ben-Ami H: Fatal liver necrosis associated with the use of nitrofurantoin. IMAJ. 2001, 3: 382-383.PubMed Edoute Y, Karmon Y, Roguin A, Ben-Ami H: Fatal liver necrosis associated with the use of nitrofurantoin. IMAJ. 2001, 3: 382-383.PubMed
10.
go back to reference Stricker BH, Blok AP, Claas FH, Van Parys GE, Desmet VJ: Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology. 1988, 8: 599-606. 10.1002/hep.1840080327.CrossRefPubMed Stricker BH, Blok AP, Claas FH, Van Parys GE, Desmet VJ: Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology. 1988, 8: 599-606. 10.1002/hep.1840080327.CrossRefPubMed
11.
go back to reference Dam-Larsen S, Kromann-Andersen H: Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998. Ugeskr Laeger. 1999, 161: 6650-6652.PubMed Dam-Larsen S, Kromann-Andersen H: Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998. Ugeskr Laeger. 1999, 161: 6650-6652.PubMed
12.
go back to reference D'Arcy PF: Nitrofurantoin. Drug Intell Clin Pharm. 1985, 19 (7-8): 540-547.PubMed D'Arcy PF: Nitrofurantoin. Drug Intell Clin Pharm. 1985, 19 (7-8): 540-547.PubMed
13.
go back to reference Liu ZX, Kaplowitz N: Immune-mediated drug-induced liver disease. Clin Liver Dis. 2002, 6: 755-774. 10.1016/S1089-3261(02)00025-9.CrossRefPubMed Liu ZX, Kaplowitz N: Immune-mediated drug-induced liver disease. Clin Liver Dis. 2002, 6: 755-774. 10.1016/S1089-3261(02)00025-9.CrossRefPubMed
14.
go back to reference Thiim M Friedman L: Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis. 2003, 7: 381-399. 10.1016/S1089-3261(03)00021-7.CrossRefPubMed Thiim M Friedman L: Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis. 2003, 7: 381-399. 10.1016/S1089-3261(03)00021-7.CrossRefPubMed
15.
go back to reference Paiva LA, Wright PJ, Koff RS: Long term hepatic memory for hypersensitivity to nitrofurantoin. Am J Gastroenterol. 1992, 87: 891-893.PubMed Paiva LA, Wright PJ, Koff RS: Long term hepatic memory for hypersensitivity to nitrofurantoin. Am J Gastroenterol. 1992, 87: 891-893.PubMed
16.
go back to reference Reinhart HH, Reinhart E, Korlipara P, Peleman R: Combined nitrofurantoin toxicity to liver and lung. Gastroenterology. 1992, 102: 1396-1399.CrossRefPubMed Reinhart HH, Reinhart E, Korlipara P, Peleman R: Combined nitrofurantoin toxicity to liver and lung. Gastroenterology. 1992, 102: 1396-1399.CrossRefPubMed
17.
go back to reference Peall AF, Hodges A: Concomitant pulmonary and hepatic toxicity secondary to nitrofurantoin: a case report. J Med Case Reports. 2007, 1: 59-61. 10.1186/1752-1947-1-59.CrossRefPubMedCentral Peall AF, Hodges A: Concomitant pulmonary and hepatic toxicity secondary to nitrofurantoin: a case report. J Med Case Reports. 2007, 1: 59-61. 10.1186/1752-1947-1-59.CrossRefPubMedCentral
Metadata
Title
Autoimmune hepatitis triggered by nitrofurantoin: a case series
Authors
Sally Appleyard
Ruma Saraswati
David A Gorard
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2010
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-4-311

Other articles of this Issue 1/2010

Journal of Medical Case Reports 1/2010 Go to the issue